The services will support the institute's precision medicine programs such as Genomic Answers for Kids.
In a Phase II trial, 47 percent of patients on the immunotherapy had a complete response lasting at least 12 months.
The researchers identified candidate markers that could prove useful for purposes like predicting and monitoring response to ...
While biotechs keep testing these treatments in clinical trials and launching new products, patients remain worried about ...
As of August 31, results for more than 64,000 newborns had been returned to families, 225 of which were positive.
The new initiative aims to create a consistent, predictable regulatory approach for sponsors developing therapies for small ...
Gene therapy could offer one-time treatment for patients with common, chronic conditions, but will have to stack up against ...
NEW YORK – Danaher on Wednesday reported a 9 percent year-over-year third quarter revenue increase, prompting the firm to increase its full-year earnings per share guidance.
NEW YORK – OncoC4 said this week the China National Medical Products Administration (NMPA) has accepted two investigational new drug applications seeking to test its PD-1/VEGF bispecific antibody ...
NEW YORK – A proposal by the US Centers for Medicare and Medicaid Services (CMS) to loosen the qualifications required of directors of high-complexity clinical laboratories has drawn opposition from ...
NEW YORK – Waters and Quest Diagnostics announced on Tuesday a collaboration to expand access to at-home cervical cancer screening using the Waters’ Onclarity Self-Collection Kit and extended human ...
NEW YORK — Takara Bio USA and SPT Labtech said on Tuesday that they have agreed to develop automated sample preparation workflows that combine their respective technologies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results